Wojnowski L[au] - Search Results

Year	Number of Results
1991	2
1992	4
1993	2
1994	4
1996	1
1997	2
1998	3
1999	1
2000	2
2001	4
2002	3
2003	2
2004	7
2005	7
2006	8
2007	9
2008	7
2009	6
2010	2
2011	1
2012	6
2013	3
2014	6
2015	2
2016	1
2017	1
2018	1
2019	2
2022	2

1

[Chemotherapeutics-induced heart failure].

Paulides M, Wojnowski L. Paulides M, et al. Among authors: wojnowski l. Med Klin (Munich). 2007 Jul 15;102(7):574-8. doi: 10.1007/s00063-007-1071-y. Med Klin (Munich). 2007. PMID: 17634876 Review. German.

2

Genotyping the risk of anthracycline-induced cardiotoxicity.

Deng S, Wojnowski L. Deng S, et al. Among authors: wojnowski l. Cardiovasc Toxicol. 2007;7(2):129-34. doi: 10.1007/s12012-007-0024-2. Cardiovasc Toxicol. 2007. PMID: 17652817 Review.

3

Clinical implications of CYP3A polymorphisms.

Wojnowski L, Kamdem LK. Wojnowski L, et al. Expert Opin Drug Metab Toxicol. 2006 Apr;2(2):171-82. doi: 10.1517/17425255.2.2.171. Expert Opin Drug Metab Toxicol. 2006. PMID: 16866606 Review.

4

Cytochrome P450 3A and their regulation.

Burk O, Wojnowski L. Burk O, et al. Among authors: wojnowski l. Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):105-24. doi: 10.1007/s00210-003-0815-3. Epub 2003 Oct 21. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14569421 Review.

5

Genetics of the variable expression of CYP3A in humans.

Wojnowski L. Wojnowski L. Ther Drug Monit. 2004 Apr;26(2):192-9. doi: 10.1097/00007691-200404000-00019. Ther Drug Monit. 2004. PMID: 15228164 Review.

6

TAF-ChIP: an ultra-low input approach for genome-wide chromatin immunoprecipitation assay.

Akhtar J, More P, Albrecht S, Marini F, Kaiser W, Kulkarni A, Wojnowski L, Fontaine JF, Andrade-Navarro MA, Silies M, Berger C. Akhtar J, et al. Among authors: wojnowski l. Life Sci Alliance. 2019 Jul 22;2(4):e201900318. doi: 10.26508/lsa.201900318. Print 2019 Aug. Life Sci Alliance. 2019. PMID: 31331983 Free PMC article.

7

The patched signaling pathway in tumorigenesis and development: lessons from animal models.

Hahn H, Wojnowski L, Miller G, Zimmer A. Hahn H, et al. Among authors: wojnowski l. J Mol Med (Berl). 1999 Jun;77(6):459-68. doi: 10.1007/s001099900018. J Mol Med (Berl). 1999. PMID: 10475061 Review.

8

Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research.

Vormfelde SV, Burckhardt G, Zirk A, Wojnowski L, Brockmöller J. Vormfelde SV, et al. Among authors: wojnowski l. Pharmacogenomics. 2003 Nov;4(6):701-34. doi: 10.1517/phgs.4.6.701.22817. Pharmacogenomics. 2003. PMID: 14596636 Review.

9

Drivers of topoisomerase II poisoning mimic and complement cytotoxicity in AML cells.

More P, Goedtel-Armbrust U, Shah V, Mathaes M, Kindler T, Andrade-Navarro MA, Wojnowski L. More P, et al. Among authors: wojnowski l. Oncotarget. 2019 Sep 3;10(51):5298-5312. doi: 10.18632/oncotarget.27112. eCollection 2019 Sep 3. Oncotarget. 2019. PMID: 31523390 Free PMC article.

10

Health-Relevant Phenotypes in the Offspring of Mice Given CAR Activators Prior to Pregnancy.

Dietrich K, Baumgart J, Eshkind L, Reuter L, Gödtel-Armbrust U, Butt E, Musheev M, Marini F, More P, Grosser T, Niehrs C, Wojnowski L, Mathäs M. Dietrich K, et al. Among authors: wojnowski l. Drug Metab Dispos. 2018 Nov;46(11):1827-1835. doi: 10.1124/dmd.118.082925. Epub 2018 Aug 28. Drug Metab Dispos. 2018. PMID: 30154105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results